AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
ADDITION OF SALMETEROL VERSUS DOUBLING THE DOSE OF BECLOMETHASONE IN CHILDREN WITH ASTHMA
Authors: VERBERNE AAPH FROST C DUIVERMAN EJ GROL MH KERREBIJN KF RAAYMAKERS JAM POCOCK SJ BOGAARD JM VANNIEROP JC NAGELKERKE AF THIO B SCHOUTEN TJ VANESSENZANDVLIET EEM DENTENEER A GERRITSEN J GROL MJ ROORDA RJ HENDRIKS JJE DUIVERMAN EJ KOUWENBERG JM VANDERLAAG J BRACKEL HJL
Citation: Aaph. Verberne et al., ADDITION OF SALMETEROL VERSUS DOUBLING THE DOSE OF BECLOMETHASONE IN CHILDREN WITH ASTHMA, American journal of respiratory and critical care medicine, 158(1), 1998, pp. 213-219
THE HOPE AND THE HAZARDS OF USING COMPLIANCE DATA IN RANDOMIZED CONTROLLED TRIALS
Authors: POCOCK SJ ABDALLA M
Citation: Sj. Pocock et M. Abdalla, THE HOPE AND THE HAZARDS OF USING COMPLIANCE DATA IN RANDOMIZED CONTROLLED TRIALS, Statistics in medicine, 17(3), 1998, pp. 303-317
CURRENT STATISTICAL PRIORITIES FOR CLINICAL-TRIALS
Authors: POCOCK SJ
Citation: Sj. Pocock, CURRENT STATISTICAL PRIORITIES FOR CLINICAL-TRIALS, Zhongguo yaoli xuebao, 19, 1998, pp. 63-64
DESIGN AND CURRENT STATUS OF ACTION - A CORONARY-DISEASE TRIAL INVESTIGATING OUTCOME WITH NIFEDIPINE GITS
Authors: LUBSEN J POOLEWILSON PA POCOCK SJ VANDALEN FJ BAUMANN J KIRWAN BA PARKER AB
Citation: J. Lubsen et al., DESIGN AND CURRENT STATUS OF ACTION - A CORONARY-DISEASE TRIAL INVESTIGATING OUTCOME WITH NIFEDIPINE GITS, European heart journal, 19, 1998, pp. 20-32
LONG-TERM RESULTS OF RITA-1 TRIAL - CLINICAL AND COST COMPARISONS OF CORONARY ANGIOPLASTY AND CORONARY-ARTERY BYPASS-GRAFTING
Authors: HENDERSON RA POCOCK SJ SHARP SJ NANCHAHAL K SCULPHER MJ BUXTON MJ HAMPTON JR
Citation: Ra. Henderson et al., LONG-TERM RESULTS OF RITA-1 TRIAL - CLINICAL AND COST COMPARISONS OF CORONARY ANGIOPLASTY AND CORONARY-ARTERY BYPASS-GRAFTING, Lancet, 352(9138), 1998, pp. 1419-1425
THROMBOSIS PREVENTION TRIAL - RANDOMIZED TRIAL OF LOW-INTENSITY ORAL ANTICOAGULATION WITH WARFARIN AND LOW-DOSE ASPIRIN IN THE PRIMARY PREVENTION OF ISCHEMIC-HEART-DISEASE IN MEN AT INCREASED RISK
Authors: MEADE TW WILKES HC KELLEHER CC RODERICK PJ BRENNAN PJ WILSON CW HOWARTH DJ STIRLING Y GARROW K DICKINSON CJ ROSE G MILLER GJ PEART WS BRECKENRIDGE AM GRAHAMESMITH DG POCOCK SJ ZUHRIE SR
Citation: Tw. Meade et al., THROMBOSIS PREVENTION TRIAL - RANDOMIZED TRIAL OF LOW-INTENSITY ORAL ANTICOAGULATION WITH WARFARIN AND LOW-DOSE ASPIRIN IN THE PRIMARY PREVENTION OF ISCHEMIC-HEART-DISEASE IN MEN AT INCREASED RISK, Lancet, 351(9098), 1998, pp. 233-241
ONE-YEAR TREATMENT WITH SALMETEROL COMPARED WITH BECLOMETHASONE IN CHILDREN WITH ASTHMA
Authors: VERBERNE AAPH FROST C ROORDA RJ VANDERLAAG H KERREBIJN KF RAAYMAKERS JAM POCOCK SJ BOGAARD JM VANNIEROP JC NAGELKERKE AF DANKERTROELSE JE THIO B SCHOUTEN TJ VANESSENZANDVLIET EEM DENTENEER A GERRITSEN J GROL M HENDRIKS JJE DUIVERMAN EJ KOUWENBERG JM VANDERLAAG J BRACKEL HJL VERBERNE AAPH
Citation: Aaph. Verberne et al., ONE-YEAR TREATMENT WITH SALMETEROL COMPARED WITH BECLOMETHASONE IN CHILDREN WITH ASTHMA, American journal of respiratory and critical care medicine, 156(3), 1997, pp. 688-695
TIME TRENDS IN SERUM-CHOLESTEROL BEFORE CANCER DEATH
Authors: SHARP SJ POCOCK SJ
Citation: Sj. Sharp et Sj. Pocock, TIME TRENDS IN SERUM-CHOLESTEROL BEFORE CANCER DEATH, Epidemiology, 8(2), 1997, pp. 132-136
PEAK FLOW VARIATION IN CHILDHOOD ASTHMA - RELATIONSHIP TO SYMPTOMS, ATOPY, AIRWAYS OBSTRUCTION AND HYPERRESPONSIVENESS
Authors: BRAND PLP DUIVERMAN EJ POSTMA DS WAALKENS HJ KERREBIJN KF VANESSENZANDVLIET EEM QUANJER PH SLUITER HJ POUW EM SCHOONBROOD DFME ROOS CM JANSEN HM DEGOOIJER A KERSTJENS HAM VANDERMARK TW KOETER GH DEJONG PM STERK PJ WEAVER AMJ DIJKMAN JH DEKHUIJZEN PNR FOLGERING HTM VANHERWAARDEN CLA OVERBEEK SE BOGAARD JM HILVERING C GANS SJ MENGELERS HJJ VANDERBRUGGENBOGAARTS BAHA KREUKNIET J KOUWENBERG JM PRINSEN JE GERRITSEN J KNOL K DEMONCHY JGR DEKKER FW KAPTEIN AA MERKUS PJFM POCOCK SJ HUGHES MD ROBINSON NJ BLEECKER ER MEYERS DA
Citation: Plp. Brand et al., PEAK FLOW VARIATION IN CHILDHOOD ASTHMA - RELATIONSHIP TO SYMPTOMS, ATOPY, AIRWAYS OBSTRUCTION AND HYPERRESPONSIVENESS, The European respiratory journal, 10(6), 1997, pp. 1242-1247
LINEARLY DIVERGENT TREATMENT EFFECTS IN CLINICAL-TRIALS WITH REPEATED-MEASURES - EFFICIENT ANALYSIS USING SUMMARY STATISTICS
Authors: FRISON LJ POCOCK SJ
Citation: Lj. Frison et Sj. Pocock, LINEARLY DIVERGENT TREATMENT EFFECTS IN CLINICAL-TRIALS WITH REPEATED-MEASURES - EFFICIENT ANALYSIS USING SUMMARY STATISTICS, Statistics in medicine, 16(24), 1997, pp. 2855-2872
LONG-TERM SURVIVAL IN PATIENTS WITH ADVANCED IMMUNODEFICIENCY
Authors: CHENE G EASTERBROOK PJ JUSZCZAK E YU LM POCOCK SJ GAZZARD BG
Citation: G. Chene et al., LONG-TERM SURVIVAL IN PATIENTS WITH ADVANCED IMMUNODEFICIENCY, AIDS, 11(2), 1997, pp. 209-216
CLINICAL-TRIALS WITH MULTIPLE OUTCOMES - A STATISTICAL PERSPECTIVE ONTHEIR DESIGN, ANALYSIS, AND INTERPRETATION
Authors: POCOCK SJ
Citation: Sj. Pocock, CLINICAL-TRIALS WITH MULTIPLE OUTCOMES - A STATISTICAL PERSPECTIVE ONTHEIR DESIGN, ANALYSIS, AND INTERPRETATION, Controlled clinical trials, 18(6), 1997, pp. 530-545
COMPLIANCE AND ADVERSE EVENT WITHDRAWAL - THEIR IMPACT ON THE WEST OFSCOTLAND CORONARY PREVENTION STUDY
Authors: SHEPHERD J COBBE SM LORIMER AR MCKILLOP JH FORD I PACKARD CJ MACFARLANE PW ISLES C OLIVER MF LEVER AF BROWN BW LEDINGHAM JGG POCOCK SJ RIFKIND BM VALLANCE BD LORIMER AR BALLANTYNE D ANDERSON L DUNCAN D KEAN S LAWRENCE A MCGRATH J MONTGOMERY V NORRIE J PERCY M POMPHREY E WHITEHOUSE A CAMERON P PARKER P PORTEOUS F FLETCHER L KILDAY C SHOAT D LATIF S KENNEDY J BELL M BIRRELL R MELLIES M MAYERS J CAMPBELL W
Citation: J. Shepherd et al., COMPLIANCE AND ADVERSE EVENT WITHDRAWAL - THEIR IMPACT ON THE WEST OFSCOTLAND CORONARY PREVENTION STUDY, European heart journal, 18(11), 1997, pp. 1718-1724
CORONARY ANGIOPLASTY VERSUS MEDICAL THERAPY FOR ANGINA - THE 2ND RANDOMIZED INTERVENTION TREATMENT OF ANGINA (RITA-2) TRIAL
Authors: CHAMBERLAIN DA FOX KAA HENDERSON RA JULIAN DG PARKER DJ POCOCK SJ MEADE TW COBBE SM EVANS SJW HAMPTON JR JOY MD HOLMBERG S SHAW DB CLAYTON T MARLEY C YOUARD B ILSLEY C FARREL T PAUL V KNIGHT R BROOKS N BENNETT D BRAY C LEVY R WARD C COPPINGER T PUMPHREY C BRECKER S WARD D MURTAGH AM BUCKNALL C BRENNANDROPER D CHAMBERS J COOKE R JACKSON G HOLT P SULKE N TAN K KARANI S OKEEFE DB MURTAGH JG RICHARDSON SG SCOTT ME GRAFFIN S BALCON R LAYTON C MILLS P ROTHMAN M TIMMIS A ATKINS C MACKINTOSH AF LARKIN H LEWIS RV STOKER JB TAN LB WILLIAMS GJ BROWN Y PITTSCRICK J BARNES E BOREHAM P CHAMBERLAINWEBBER R PAPOUCHADO M HALESTRAP M TAGNEY J SWANTON RH WALKER JM FIRMAN E REID D ADAMS PC BEXTON R EVEMY K FURNISS S WILLIAMS D MCDERMOTT A JEWITT D RICHARDSON P THOMAS M WAINWRIGHT RJ JACOB A MAURER B BUCKLEY A DINN E BEGLEY F WATSON R SINGH SP CADD L PERRY R EPSTEIN G CAREY R CREAN P GHAISAS N HUGHES D DYMOND D BANIM S NATHAN AW SPURRELL RAJ JONES H ELSTOB J GRIBBIN B FORFAR C ORMEROD O LONGNEY T GRAY H DAWKINS K SEYMOUR J SIMPSON I MCGUIRK M SHIU MJ SUGRUE D EGAN B HOLIGAN B
Citation: Da. Chamberlain et al., CORONARY ANGIOPLASTY VERSUS MEDICAL THERAPY FOR ANGINA - THE 2ND RANDOMIZED INTERVENTION TREATMENT OF ANGINA (RITA-2) TRIAL, Lancet, 350(9076), 1997, pp. 461-468
CORONARY ANGIOPLASTY VERSUS MEDICAL THERAPY FOR ANGINA - INTERIM RESULTS OF THE 2ND RANDOMIZED INTERVENTION TREATMENT OF ANGINA TRIAL
Authors: HENDERSON RA CLAYTON TC POCOCK SJ CHAMBERLAIN DA
Citation: Ra. Henderson et al., CORONARY ANGIOPLASTY VERSUS MEDICAL THERAPY FOR ANGINA - INTERIM RESULTS OF THE 2ND RANDOMIZED INTERVENTION TREATMENT OF ANGINA TRIAL, Circulation, 96(8), 1997, pp. 2609-2609
BASE-LINE RISK-FACTORS AND THEIR ASSOCIATION WITH OUTCOME IN THE WESTOF SCOTLAND CORONARY PREVENTION STUDY
Authors: SHEPHERD J COBBE SM LORIMER AR MCKILLOP JH FORD I PACKARD CJ MACFARLANE PW ISLES C OLIVER MF LEVER AF BROWN BW LEDINGHAM JGG POCOCK SJ RIFKIND BM VALLANCE BD MCKILLIP JH BALLANTYNE D NORRIE J ANDERSON L DUNCAN D KEAN S LAWRENCE A MCGRATH J MONTGOMERY V PERCY M POMPHREY E WHITEHOUSE A CAMERON P PARKER P PORTEOUS F FLETCHER L KILDAY C SHOAT D LATIF S KENNEDY J BELL MA BIRRELL R MELLIES M MEYER J CAMPBELL W
Citation: J. Shepherd et al., BASE-LINE RISK-FACTORS AND THEIR ASSOCIATION WITH OUTCOME IN THE WESTOF SCOTLAND CORONARY PREVENTION STUDY, The American journal of cardiology, 79(6), 1997, pp. 756-762
RIFABUTIN VERSUS PLACEBO IN COMBINATION WITH 3 DRUGS IN THE TREATMENTOF NONTUBERCULOUS MYCOBACTERIAL INFECTION IN PATIENTS WITH AIDS
Authors: DAUTZENBERG B OLLIARO P RUF B ESPOSITO R OPRAVIL M HOY JF ROZENBAUM W CAROSI GP MICOUD M LAGE M PIROTTA N SASSELLA D COULAUD JP VILDE JL GENTILINI M CAUBARRERE I CAQUET R WEINBRECK P LEBEAU B HUMBERT G MODAI J ARMENGAUD M DUFFAUT M DUJARDIN P DELLAMONICA P MOUTON Y GALLAIS H GASTAUD JA GENIAUX M SUERI L BARNI C CALIGARIS S ELHAMAD I ERRANTE I MORONI M FRANZETTI F CARGNEL A DEDIVITIIS GF MARONE P PASTICCI MB HELM EB RUHNKE M SCHURMANN D SCHULER W ERCKENBRECHT I HEISE W BROCKMEYER N DIETRICH M JONES P GROSSET J PENATI V MAUCH H SALFINGER M DWYER B GILBERT L DESLANDES JY DOLFI L GLANZMANN I HARRIS M HERCEG R LANDI V MORELLI P SCOLA E WEINIG S KUNIN MC CARBON NC GRASSI G NORRBY SR POCOCK SJ
Citation: B. Dautzenberg et al., RIFABUTIN VERSUS PLACEBO IN COMBINATION WITH 3 DRUGS IN THE TREATMENTOF NONTUBERCULOUS MYCOBACTERIAL INFECTION IN PATIENTS WITH AIDS, Clinical infectious diseases, 22(4), 1996, pp. 705-708
A COMPARISON OF ASPIRIN AND ANTICOAGULATION FOLLOWING THROMBOLYSIS FOR MYOCARDIAL-INFARCTION (THE AFTER STUDY) - A MULTICENTER UNBLINDED RANDOMIZED CLINICAL-TRIAL
Authors: JULIAN DG CHAMBERLAIN DA POCOCK SJ
Citation: Dg. Julian et al., A COMPARISON OF ASPIRIN AND ANTICOAGULATION FOLLOWING THROMBOLYSIS FOR MYOCARDIAL-INFARCTION (THE AFTER STUDY) - A MULTICENTER UNBLINDED RANDOMIZED CLINICAL-TRIAL, BMJ. British medical journal, 313(7070), 1996, pp. 1429-1431
STATISTICAL REPORTING OF CLINICAL-TRIALS WITH INDIVIDUAL CHANGES FROMALLOCATED TREATMENT
Authors: WHITE IR POCOCK SJ
Citation: Ir. White et Sj. Pocock, STATISTICAL REPORTING OF CLINICAL-TRIALS WITH INDIVIDUAL CHANGES FROMALLOCATED TREATMENT, Statistics in medicine, 15(3), 1996, pp. 249-262
THE ROLE OF EXTERNAL EVIDENCE IN DATA MONITORING OF A CLINICAL-TRIAL
Authors: POCOCK SJ
Citation: Sj. Pocock, THE ROLE OF EXTERNAL EVIDENCE IN DATA MONITORING OF A CLINICAL-TRIAL, Statistics in medicine, 15(12), 1996, pp. 1285-1293
BLINDING DURING DATA-ANALYSIS AND WRITING OF MANUSCRIPTS - DISCUSSION
Authors: POCOCK SJ
Citation: Sj. Pocock, BLINDING DURING DATA-ANALYSIS AND WRITING OF MANUSCRIPTS - DISCUSSION, Controlled clinical trials, 17(4), 1996, pp. 292-293
WEST OF SCOTLAND CORONARY PREVENTION STUDY - IDENTIFICATION OF HIGH-RISK GROUPS AND COMPARISON WITH OTHER CARDIOVASCULAR INTERVENTION TRIALS
Authors: SHEPHERD J COBBE SM LORIMER AR MCKILLOP JH FORD I PACKARD CJ MACFARLANE PW ISLES C OLIVER MF LEVER AF BROWN BW LEDINGHAM JGG POCOCK SJ RIFKIND BM VALLANCE BD BALLANTYNE D ANDERSON L DUNCAN D KEAN S LAWRENCE A MCGRATH J MONTGOMERY V NORRIE J PERCY M POMPHREY E WHITEHOUSE A CAMERON P PARKER P PORTEOUS F FLETCHER L KILDAY C SHOAT D LATIF S KENNEDY J BELL MA BIRRELL R MELLIES M MEYER J CAMPBELL W
Citation: J. Shepherd et al., WEST OF SCOTLAND CORONARY PREVENTION STUDY - IDENTIFICATION OF HIGH-RISK GROUPS AND COMPARISON WITH OTHER CARDIOVASCULAR INTERVENTION TRIALS, Lancet, 348(9038), 1996, pp. 1339-1342
ANGIOPLASTY VERSUS BYPASS-SURGERY - REPLY
Authors: HENDERSON RA POCOCK SJ
Citation: Ra. Henderson et Sj. Pocock, ANGIOPLASTY VERSUS BYPASS-SURGERY - REPLY, Lancet, 347(8996), 1996, pp. 272-273
IS DELAYED INTRODUCTION OF INHALED CORTICOSTEROIDS HARMFUL IN PATIENTS WITH OBSTRUCTIVE AIRWAYS DISEASE (ASTHMA AND COPD)
Authors: OVERBEEK SE KERSTJENS HAM BOGAARD JM MULDER PGH POSTMA DS KERREBIJN KF QUANJER PH SLUITER HJ POUW EM SCHOONBROOD DFME ROOS CH JANSEN HM BRAND PLP DEGOOIJER A VANDERMARK TW KOETER GH DEJONG PM STERK PJ WEVER AMJ DIJKMAN JH DEKHUIJZEN PNR FOLGERING H VANHERWAARDEN CLA HILVERING C MENGELERS SJ GANS SJ VANDERBRUGGEN B KREUKNIET J VANESSENZANDVLIET EEM DUIVERMAN EJ KOUWENBERG JM PRINSEN JE WAALKENS HJ GERRITSEN J KNOL K DEMONCHY JGR KAPTEIN AA DEKKER FW MERKUS PJFM HUGHES MD ROBINSON NJ POCOCK SJ BLEECKER ER MEYERS DA
Citation: Se. Overbeek et al., IS DELAYED INTRODUCTION OF INHALED CORTICOSTEROIDS HARMFUL IN PATIENTS WITH OBSTRUCTIVE AIRWAYS DISEASE (ASTHMA AND COPD), Chest, 110(1), 1996, pp. 35-41
QUALITY-OF-LIFE, EMPLOYMENT STATUS, AND ANGINAL SYMPTOMS AFTER CORONARY ANGIOPLASTY OR BYPASS-SURGERY - 3-YEAR FOLLOW-UP IN THE RANDOMIZED INTERVENTION TREATMENT OF ANGINA (RITA) TRIAL
Authors: POCOCK SJ HENDERSON RA SEED P TREASURE T HAMPTON JR
Citation: Sj. Pocock et al., QUALITY-OF-LIFE, EMPLOYMENT STATUS, AND ANGINAL SYMPTOMS AFTER CORONARY ANGIOPLASTY OR BYPASS-SURGERY - 3-YEAR FOLLOW-UP IN THE RANDOMIZED INTERVENTION TREATMENT OF ANGINA (RITA) TRIAL, Circulation, 94(2), 1996, pp. 135-142
Risultati: 1-25 | 26-43